Fig. 4From: rhG-CSF is associated with an increased risk of metastasis in NSCLC patients following postoperative chemotherapySubgroup analyses on effect of rhG-CSF on tumor metastasis in postoperative NSCLC patients accepted chemotherapy during different follow-up times. A-C Follow-up postoperative NSCLC patients accepted chemotherapy 1, 2, and 3 yearsBack to article page